Kenvue (NYSE:KVUE) (NYSE:KVUE) is a global consumer health company that was established in 2023 following its separation from Johnson & Johnson. The company houses a portfolio of well-known over-the-counter and personal care brands, carrying forward a legacy that spans more than a century of innovation in health and wellness. With its headquarters in New Brunswick, New Jersey, Kenvue began independent trading as part of a strategic move to focus solely on consumer health products while leveraging the deep brand equity and research capabilities inherited from its predecessor.
The company’s product offerings span several core categories, including pain relief, skin health, oral care, baby care and women’s health. Signature brands under the Kenvue umbrella include Tylenol, Neutrogena, Aveeno, Listerine and Johnson’s Baby. Kenvue’s portfolio also encompasses digestive health solutions and nutritional supplements, backed by a focus on science-driven formulation and consumer-focused innovation. Research and development efforts target both the enhancement of existing product lines and the introduction of new offerings that address emerging health and wellness trends.
Operating in more than 100 countries, Kenvue employs a multi-channel distribution strategy that includes retail pharmacies, mass merchandisers, grocery chains and e-commerce platforms. The company’s global supply chain is supported by manufacturing facilities and partnerships across North America, Europe, Asia-Pacific and Latin America. Kenvue places emphasis on expanding access to affordable healthcare products in emerging markets while optimizing its footprint in established markets through sustainable sourcing and packaging initiatives.
Leadership at Kenvue is headed by Chief Executive Officer Thibaut Mongon, whose background in consumer products and healthcare drives the company’s strategic direction. The senior management team brings decades of combined experience in brand management, product innovation and global operations. Kenvue’s governance framework emphasizes environmental, social and corporate responsibility, with objectives that include reducing carbon emissions, enhancing supply chain transparency and supporting community health programs worldwide.
